Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
Gosens R, Zaagsma J, Meurs H, Halayko AJ. · 2006
Read Muscarinic receptor signaling in the pathophysiology of asthma and COPD. by Gosens R, Zaagsma J, Meurs H, Halayko AJ. (2006) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1479816.txt.
Description
Drugs that block acetylcholine, a nerve signal, open airways in lung disease. Gosens and co-authors reviewed in 2006 whether the signal does more than tighten airway muscle. In asthma and COPD, airway swelling raises nerve tone and acetylcholine release. The signal also drives mucus output.
Fresh work links the signal to airway wall thickening, a lasting change called remodeling. Many airway cells, not just nerves, make acetylcholine and bear its receptors. Gosens notes one blocking drug slows lung decline in COPD, hinting at wider action. The review argues these drugs may help beyond quick relief of tight airways.
Catalog record
| CREATOR | Gosens R, Zaagsma J, Meurs H, Halayko AJ. |
|---|---|
| YEAR | 2006 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 76 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |